Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Eli lilly and company    save search

FDA Roundup: December 5, 2023
Published: 2023-12-05 (Crawled : 14:30) - fda.gov
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

fda
Metastatic Castration-Sensitive Prostate Cancer Market to Skyrocket at Astounding 22% CAGR During the Study Period (2019-2032), assesses DelveInsight
Published: 2023-12-06 (Crawled : 22:00) - prnewswire.com
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 0.0% C: 0.0%

cancer study market
The Top 12 Biopharma Companies Hiring Now
Published: 2023-12-06 (Crawled : 22:00) - biospace.com/
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

companies biopharma
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
NVS | News 0 d | $95.93 -1.15% 0.0% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.0% C: 0.0%
GSK | News | $36.0 -0.47% 0.06% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.03% H: 0.0% C: 0.0%
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%
ABBV | News | $147.97 1.09% 0.05% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 0.0% C: 0.0%
DNLI | News | $18.72 -2.19% -2.24% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.22% H: 0.0% C: 0.0%
BIIB | News | $239.14 2.25% 2.2% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.46% H: 0.0% C: 0.0%

disease parkinson's revenue research therapeutics market
Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors
Published: 2023-12-06 (Crawled : 15:30) - biospace.com/
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%


Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Published: 2023-12-06 (Crawled : 01:00) - prnewswire.com
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%
SNY | News | $46.06 0.17% 0.17% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.0% C: 0.0%
INCY | News | $55.17 -0.45% -0.45% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 0.0% C: 0.0%

rient-16 treatment results study
FDA Roundup: December 05, 2023
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

fda
Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis
Published: 2023-12-04 (Crawled : 23:00) - prnewswire.com
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 0.0% C: 0.0%
VNDA | $3.96 -1.98% -2.02% 1.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.13% H: 1.53% C: 0.76%

drug food treatment pharmaceuticals application
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023
Published: 2023-12-04 (Crawled : 14:30) - biospace.com/
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.96% H: 0.0% C: 0.0%

biopharma acquire
Jaypirca® (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor
Published: 2023-12-01 (Crawled : 23:00) - prnewswire.com
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

jaypirca fda approved treatment leukemia
Verve Therapeutics Announces Closing of Public Offering of Common Stock, Full Exercise by Underwriters of Option to Purchase Additional Shares and Closing of Concurrent Private Placement
Published: 2023-12-01 (Crawled : 21:00) - globenewswire.com
VERV 5 d | $12.89 3.2% 3.1% 1.4M twitter stocktwits trandingview |
Professional, Scientific, and T...
| Email alert Add to watchlist
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

offering therapeutics
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
Published: 2023-12-01 (Crawled : 17:00) - globenewswire.com
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.0% C: 0.0%
ACIU | $3.55 -0.56% -0.56% 85K twitter stocktwits trandingview |
Health Technology
| | O: 2.64% H: 0.0% C: 0.0%


Acute Myocardial Infarction Treatment Market to Show Immense Growth at a CAGR of 7.7% During the Study Period (2019-2032), Predicts DelveInsight
Published: 2023-11-30 (Crawled : 22:00) - prnewswire.com
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.0% C: 0.0%

treatment show growth study market
Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
Published: 2023-11-30 (Crawled : 08:00) - biospace.com/
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 0.81% C: -0.07%
FGEN | $0.6172 6.41% 6.03% 930K twitter stocktwits trandingview |
Health Technology
| | O: 10.37% H: 11.13% C: 4.23%

pharma
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
Published: 2023-11-29 (Crawled : 04:00) - globenewswire.com
VERV 5 d | $12.89 3.2% 3.1% 1.4M twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -7.79% H: 13.21% C: 5.66%
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.0% C: 0.0%

offering therapeutics
Metastatic Non-small Cell Lung Cancer Market Forecast Analysis and with Focus on its Immune/Molecular Biomarker Types: PD-L1, EGFR, KRAS, ALK, BRAF, MET, ROS-1, HER2, RET fusion, and NTRK1/2/3 Gene fusion | DelveInsight
Published: 2023-11-28 (Crawled : 22:00) - prnewswire.com
JNJ | News | $155.4 -0.78% -0.02% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 0.0% C: 0.0%
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.0% C: 0.0%
SNY | News | $46.06 0.17% 0.17% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 0.07% C: -0.66%
BPMC | $73.75 1.84% 1.8% 650K twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 1.86% C: -0.33%

lung biomarker cancer cell market
Verve Therapeutics Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
VERV 5 d | $12.89 3.2% 3.1% 1.4M twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -7.79% H: 13.21% C: 5.66%
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.0% C: 0.0%

offering therapeutics
Alexandria Real Estate Equities, Inc. Announces Exclusive Partnership With Lilly to Expand Lilly Gateway Labs to San Diego
Published: 2023-11-28 (Crawled : 21:00) - biospace.com/
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 0.0% C: 0.0%
ARE A | $121.96 0.11% 0.0% 1.6M twitter stocktwits trandingview |
Finance
| | O: -0.19% H: 3.05% C: 2.77%

partnership
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
Published: 2023-11-28 (Crawled : 20:00) - prnewswire.com
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.0% C: 0.0%

drug prism collaboration
Sermonix Pharmaceuticals Announces Five Abstracts Accepted for Presentation at 2023 San Antonio Breast Cancer Symposium
Published: 2023-11-28 (Crawled : 15:30) - biospace.com/
LLY | News 5 d | $588.27 -0.17% -0.1% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 0.0% C: 0.0%
LGND | News F | $61.34 2.63% 2.56% 110K twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 0.83% C: -2.14%

breast symposium presentation cancer pharmaceuticals
Gainers vs Losers
69% 31%

Top 10 Gainers
SLDB M | $5.89 72.22% 41.94% 12M twitter stocktwits trandingview |
Health Technology

SVFD | $3.09 43.72% 30.42% 64M twitter stocktwits trandingview |

FTEL | $2.04 43.66% 30.39% 110K twitter stocktwits trandingview |

HPCO 4 | $0.4824 41.92% 29.54% 28M twitter stocktwits trandingview |

ALGS | $0.6475 -5.06% 26.67% 2.1M twitter stocktwits trandingview |
Health Technology

GTHX | $3.16 30.58% 23.42% 10M twitter stocktwits trandingview |
Health Technology

KEQU | News | $22.5 27.62% 21.64% 24K twitter stocktwits trandingview |
Producer Manufacturing

GSIT | $3.09 27.16% 21.36% 2.2M twitter stocktwits trandingview |
Electronic Technology

SSKN P | $0.628 25.6% 20.38% 210K twitter stocktwits trandingview |
Health Technology

GLUE | $3.66 22.82% 18.58% 510K twitter stocktwits trandingview |
Professional, Scientific, and T...


Your saved searches
Save your searches and get alerts when important news are released.